CD5 and neoplasm: Resistance of tumor cells to cytarabine correlated with the expression of Ki-67 (r = 0.33) and T-cell markers (CD2, r = 0.22; CD3, r = 0.25; and CD5, r = 0.14), but not with immaturity markers (Table S5).